9:00am – 9:10am: |
Welcome and Introduction to Biomarkers in Diagnostics
Speaker: Jagan Pillai, MD, PhD
Pre-test; disclosures; virtual housekeeping |
9:10am – 9:45am: |
New AD Biomarkers: What They Are and Where They Came From
Speaker: Charles Bernick, MD, MPH
Background on AD pathology and introduction of specific AD biomarkers, both fluid (blood and CSF) and PET amyloid imaging. |
9:45am – 10:20am: |
Deploying AD Biomarkers in the Clinic Part I: Evaluation of the Patient with Cognitive Impairment
Speaker: Jagan Pillai, MD, PhD
General diagnostic approaches and use of traditional testing. |
10:20am – 10:55am: |
Deploying AD Biomarkers in the Clinic Part II: Where do Biomarkers Fit?
Speaker: Lakeshia Gibson, MD
When to order new AD biomarkers and who should we order them for. |
10:55am – 11:05am: |
Break
|
11:05am – 11:40am: |
Interpreting Biomarkers, Informing Patients and Referral Pathways
Speaker: Dylan Wint, MD
Biomarker limitations, how to discuss results with patients and appropriate specialty referrals. |
11:40am – 11:50am: |
Panel Discussion/Closing Remarks
Speaker: All |
11:50am – 12:00pm: |
Wrap-up; Posttest, Evaluation, AdjournSpeaker: Charles Bernick, MD, MPH
|
